Astragalus (Huang Qi)

Updated June 29, 2026

Astragalus membranaceus (also known as Huang Qi, or milk vetch root) is one of the most widely used herbs in Traditional Chinese Medicine, with a documented history spanning over two thousand years. It is classified as a superior tonic — an adaptogen used to tonify the wei qi (protective life energy), strengthen immunity, and support longevity. In modern nutritional science it has attracted serious research attention, primarily because one of its active compounds, cycloastragenol, appears to activate telomerase, the enzyme responsible for maintaining telomere length in human cells.

The root contains a complex mixture of bioactives: astragalosides (saponins, including astragaloside IV and cycloastragenol), polysaccharides, flavonoids, and amino acids. The polysaccharides are largely responsible for immune-modulating effects, while the astragalosides drive the telomere and anti-aging research. Cycloastragenol is derived from astragaloside IV and became widely known when it was commercialised as TA-65, a product patented and sold by a biotech company at very high price points. TA-65 itself has been studied in several small human trials showing modest improvements in immune cell telomere length.

Immune support is where the human evidence is most consistent. Multiple controlled trials in patients with immune challenges — including those undergoing chemotherapy and elderly individuals with reduced immune function — show that astragalus root extracts significantly increase natural killer cell activity, T-cell proliferation, and interferon production. The effect is broad-spectrum immune enhancement rather than stimulation of any one branch. Some meta-analyses of Traditional Chinese Medicine practice in oncology settings have found that astragalus-containing formulas reduce chemotherapy side effects and improve quality-of-life markers, though these are complex formulas, not astragalus alone.

The telomere angle is genuinely interesting but should be approached with measured expectations. Telomere shortening is one of the hallmarks of cellular ageing, and telomerase activation theoretically slows or partially reverses this process. Cycloastragenol activates hTERT, the catalytic subunit of telomerase, in vitro and in vivo. Human trials with TA-65 have shown measurable increases in the percentage of cells with longer telomeres. What this means clinically — whether it translates to extended lifespan, reduced disease incidence, or improved function — is not established in humans. The theoretical concern that activating telomerase could promote cancer (since cancer cells are often immortal through exactly this mechanism) has been studied and appears unlikely at physiological doses, but long-term data in humans is limited.

Additional documented benefits include cardiovascular support (blood pressure normalisation, reduced LDL oxidation), kidney protection in diabetic nephropathy models, and mild antidiabetic effects via improved insulin sensitivity. Astragalus is well tolerated with very few adverse events reported across its long history of human use. Standard supplemental dosing ranges from 500 mg to 3 g of root extract daily, or specialised cycloastragenol extracts at 5 to 25 mg/day for telomere-focused protocols. This is general information, not medical advice.